Crinetics Pharmaceuticals, Inc. · NASDAQ:CRNX
The Vanguard Group reported a 9.80% stake in Crinetics Pharmaceuticals, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Jan 30, 2025
The Vanguard Group reported a 9.80% stake in Crinetics Pharmaceuticals, Inc., 9,089,391 shares, as a passive investor on Dec 31, 2024. Filed Jan 30, 2025 (Schedule 13G/A).
- Stake
- 9.80%
- Shares
- 9,089,391
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 9.80% | 9,089,391 |
Source
Related
- Crinetics Pharmaceuticals, Inc.
- The Vanguard Group
- Crinetics Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Mar 26, 2026
- Schedule 13G/A · The Vanguard Group · Apr 7, 2025
- Form 4 · Wierenga Wendell · Sep 1, 2026
- Form 4 · Vivaldi Coelho Rogerio · Sep 1, 2026
- Form 4 · Okey Stephanie · Sep 1, 2026
- Form 4 · Nichols Weston · Sep 1, 2026
- Form 4 · Fust Matthew K · Sep 1, 2026